How does Abbott Laboratories (ABT) make money?

Abbott Laboratories (ABT) primarily makes money through Medical Devices, which accounts for 42.3% of total revenue. For TTM through Q1 2026, Abbott Laboratories generated $45.13B in total revenue with a net profit margin of 13.9%.

What is Abbott Laboratories (ABT) gross profit margin?

Abbott Laboratories (ABT) reported a gross profit margin of 56.4% for TTM through Q1 2026, equivalent to $25.45B in gross profit. This means Abbott Laboratories retains 56.4% of each revenue unit after direct costs of production.

What is Abbott Laboratories (ABT) operating profit margin?

Abbott Laboratories (ABT) reported an operating profit margin of 18.2% for TTM through Q1 2026, equivalent to $8.20B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.

What is Abbott Laboratories (ABT) net profit margin?

Abbott Laboratories (ABT) reported a net profit margin of 13.9% for TTM through Q1 2026, equivalent to $6.28B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.

How much does Abbott Laboratories (ABT) invest in R&D?

Abbott Laboratories (ABT) invested $3.01B in research and development in TTM through Q1 2026 (6.7% of total revenue). R&D spending reflects investment in future products, services, and technologies.

How much does Abbott Laboratories (ABT) spend on capital expenditures?

Abbott Laboratories (ABT) spent $2.17B on capital expenditures in TTM through Q1 2026 (4.8% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.

What is Abbott Laboratories (ABT) free cash flow?

Abbott Laboratories (ABT) generated $7.39B in free cash flow for TTM through Q1 2026 (16.4% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.

What is Abbott Laboratories (ABT) effective tax rate?

Abbott Laboratories (ABT) had an effective tax rate of 22.9% for TTM through Q1 2026. This is the actual percentage of pre-tax income paid as income taxes.

How Abbott Laboratories (ABT) Makes Money: A Visual Guide

Abbott Laboratories (ABT) generated $45.13B in revenue, earning $6.28B in net profit (13.9% margin). Its largest revenue source is Medical Devices (42.3% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.

Abbott Laboratories (ABT) Income Statement Flow — TTM through Q1 2026

Calculated from the four most recent reported quarters, ending March 31, 2026 (reported March 31, 2026).

Frequently asked questions

How does Abbott Laboratories (ABT) make money?: Abbott Laboratories (ABT) primarily makes money through Medical Devices, which accounts for 42.3% of total revenue. For TTM through Q1 2026, Abbott Laboratories generated $45.13B in total revenue with a net profit margin of 13.9%.
What is Abbott Laboratories (ABT) gross profit margin?: Abbott Laboratories (ABT) reported a gross profit margin of 56.4% for TTM through Q1 2026, equivalent to $25.45B in gross profit. This means Abbott Laboratories retains 56.4% of each revenue unit after direct costs of production.
What is Abbott Laboratories (ABT) operating profit margin?: Abbott Laboratories (ABT) reported an operating profit margin of 18.2% for TTM through Q1 2026, equivalent to $8.20B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Abbott Laboratories (ABT) net profit margin?: Abbott Laboratories (ABT) reported a net profit margin of 13.9% for TTM through Q1 2026, equivalent to $6.28B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Abbott Laboratories (ABT) invest in R&D?: Abbott Laboratories (ABT) invested $3.01B in research and development in TTM through Q1 2026 (6.7% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Abbott Laboratories (ABT) spend on capital expenditures?: Abbott Laboratories (ABT) spent $2.17B on capital expenditures in TTM through Q1 2026 (4.8% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Abbott Laboratories (ABT) free cash flow?: Abbott Laboratories (ABT) generated $7.39B in free cash flow for TTM through Q1 2026 (16.4% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is Abbott Laboratories (ABT) effective tax rate?: Abbott Laboratories (ABT) had an effective tax rate of 22.9% for TTM through Q1 2026. This is the actual percentage of pre-tax income paid as income taxes.

Data & methodology

What is a Sankey diagram?: A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
How is the data calculated?: We use the income statement from company filings. For TTM (Trailing Twelve Months), we use a pre-aggregated twelve-month view aligned with our latest four quarterly periods. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
When was this data last updated?: Based on company filings through TTM through Q1 2026.